Balyasny Asset Management LLC Puma Biotechnology, Inc. Transaction History

Balyasny Asset Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$4.29 - $7.4 $209,965 - $362,178	-48,943 Reduced 59.94%	32,709 $173,000
Q4 2023 Feb 14, 2024	BUY	$2.23 - $4.49 $182,083 - $366,617	81,652 New	81,652 $353,000
Q3 2022 Nov 14, 2022	BUY	$2.27 - $3.84 $31,441 - $53,187	13,851 New	13,851 $33,000
Q3 2019 Nov 14, 2019	SELL	$8.75 - $12.85 $829,815 - $1.22 Million	-94,836 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$12.3 - $35.76 $500,056 - $1.45 Million	40,655 Added 75.04%	94,836 $1.21 Million
Q1 2019 May 15, 2019	BUY	$20.77 - $42.37 $286,085 - $583,604	13,774 Added 34.09%	54,181 $2.1 Million
Q4 2018 Feb 14, 2019	SELL	$20.07 - $46.7 $8.03 Million - $18.7 Million	-399,962 Reduced 90.82%	40,407 $822,000
Q3 2018 Nov 14, 2018	BUY	$41.2 - $59.85 $11.5 Million - $16.6 Million	277,994 Added 171.2%	440,369 $20.2 Million
Q2 2018 Aug 14, 2018	SELL	$48.3 - $68.25 $4.96 Million - $7 Million	-102,595 Reduced 38.72%	162,375 $9.6 Million
Q1 2018 May 15, 2018	BUY	$59.7 - $99.25 $12.5 Million - $20.9 Million	210,097 Added 382.88%	264,970 $18 Million
Q4 2017 Feb 14, 2018	SELL	$93.85 - $132.45 $12.5 Million - $17.6 Million	-132,886 Reduced 70.77%	54,873 $5.42 Million
Q3 2017 Nov 14, 2017	BUY	$72.0 - $119.75 $13.5 Million - $22.5 Million	187,759	187,759 $22.5 Million

100

29M

50.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $135M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.